ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma
Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase I trial to study the effectiveness of combining ZD0473 and doxorubicin in
treating patients who have advanced solid tumors or lymphoma.